Publications by authors named "H Scher"

Claim this Profile
A
Anti-tumour effects of perioperative ketamine in lung cancer: a non-randomised, exploratory biomarker study.
Stephanie N Shishido, Anya Shah, Jeremy Mason, Joseph R Scarpa, David Amar, Gregory W Fischer, Howard Scher

Br J Anaesth· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression.
Wenjing Su, Hyun Ho Han, Yan Wang, Boyu Zhang, Bing Zhou, Howard I Scher

Cancer Cell· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.
Deaglan McHugh, Matthew Dallos, Min Yuen Teo, Sean M McBride, Anuradha Gopalan, Howard I Scher

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Decades of Disease Evolution and Biomarker-Guided Clinical Decision Making in Metastatic Prostate Cancer.
Tatiana Erazo, Enrico Moiso, Omer Aras, Howard I Scher

Int J Mol Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes.
Karen A Autio, Christos E Kyriakopoulos, Paul Palyca, Han Xiao, Hamid Emamekhoo, Howard I Scher

Invest New Drugs· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis